As for VEGFR2 staining in epithelial prostate cells, almost 70% of patients with extra prostatic carcinomas and approximately half of organ-confined carcinomas showed tumor cell immunoreactivity for VEGFR2, whereas only 25% of nodular prostate hyperplasia were positive (P = 0.035) (Fig. 2). Here, KDR is linked to neoplasm.